Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K; HPV-Pathogen ISS Study Group. Branca M, et al. Among authors: alderisio m. Am J Clin Pathol. 2004 Dec;122(6):902-11. doi: 10.1309/VQXF-T880-JXC7-QD2W. Am J Clin Pathol. 2004. PMID: 15539382
p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K. Branca M, et al. Among authors: alderisio m. Int J Gynecol Pathol. 2004 Oct;23(4):354-65. doi: 10.1097/01.pgp.0000139639.79105.40. Int J Gynecol Pathol. 2004. PMID: 15381905
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K. Branca M, et al. Among authors: alderisio m. Eur J Gynaecol Oncol. 2004;25(6):689-98. Eur J Gynaecol Oncol. 2004. PMID: 15597844
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.
Giorgi C, Di Bonito P, Grasso F, Mochi S, Accardi L, Donà MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, Syrjänen K; HPV-PathogenISS group. Giorgi C, et al. Infect Agent Cancer. 2008 Jun 26;3:9. doi: 10.1186/1750-9378-3-9. Infect Agent Cancer. 2008. PMID: 18582363 Free PMC article.
Variation in the assessment of adequacy in cervical smears.
Migliore G, Rossi E, Aldovini A, Mudu P, Alderisio M, Giovagnoli MR, Fabiano A, Morosini PL, Branca M. Migliore G, et al. Among authors: alderisio m. Cytopathology. 2001 Dec;12(6):377-82. doi: 10.1046/j.1365-2303.2001.00361.x. Cytopathology. 2001. PMID: 11843939
Human papillomavirus in virgins and behaviour at risk.
Frega A, Cenci M, Stentella P, Cipriano L, De Ioris A, Alderisio M, Vecchione A. Frega A, et al. Among authors: alderisio m. Cancer Lett. 2003 May 8;194(1):21-4. doi: 10.1016/s0304-3835(03)00048-x. Cancer Lett. 2003. PMID: 12706855
27 results